META MATERIALS STOCK HOW TO

On the date of publication, Joseph Nograles did not have (either directly or indirectly) any positions in the securities mentioned in this article.

META MATERIALS STOCK HOW TO

Read More: Penny Stocks - How to Profit Without Getting Scammed If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that ’s writers disclose this fact and warn readers of the risks. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. This in my opinion makes MMAT stock a compelling risk to reward opportunity. If the short-squeeze doesn’t pan out, you will still be left with a company that could easily 5x based on its own merits. This is why the short-squeeze situation benefits investors as it provides a short-term catalyst while waiting for the company to execute. However, I also know that the company is playing the long game and it could take years before any of its products fully take off. Meta Materials’ products could be the building blocks of tomorrow’s technology. To be clear, I think MMAT is an interesting investment even without the short squeeze. Therefore the latest Days to Cover ratio is 1.31 roughly 30% higher than it was last month increasing the likelihood of a short squeeze. However, based on the latest available data, MMAT has a short interest of 25 million shares and an average daily volume of 19 million shares. This translates to a Days to Cover ratio of approximately 1.05. At the beginning of September short interest was 22.1 million shares with an average daily volume of 21 million shares. Looking at MMAT stock’s short interest it is an even better candidate now as when it was first mentioned. This is telling of the type of strategies employed by Wall Street.Īccording to a CNBC interview last month with S3 Partners’ Ihor Dusaniwsky he mentioned MMAT as a short candidate. MMAT has very minimal analyst coverage but a lot of short interest. Unfortunately, this type of talk has overshadowed the news of the interesting things the company is developing. I can’t write an article on MMAT stock without discussing its short interest. Therefore the successful licensing or commercialization of even one of these patents could send MMAT stock skyrocketing. These patents have multiple applications in billion-dollar industries like 5G, Solar and Medical Technology. 17 patents in rolling mask lithography and transparent conductors.The breakdown of the companies patents are Last quarter alone the company was successfully granted 6 new patents. I am pleased to say that in my view the company has a solid portfolio that could support MMAT’s $1.3 billion market cap.Īt the end of Q2, Meta Materials currently has 82 patents granted and 67 patent applications. A Closer Look at MMAT StockĪs these types of investments, examining Meta Materials intellectual property portfolio and the pipeline is important. Therefore MMAT stock must be treated like early-stage biotech or pre-revenue venture capital investment.

Meta Materials’ future success is wholly dependent on the execution of its promise. The company also has no debt, meaning that there isn’t any overhang on its balance sheet. At the end of Q2 2021, Meta Materials had cash of $154.6 million.Ĭash burn for the first half of 2021 was $5.6 million which was slightly less than the cash burn of $4.5 million at the same time last year. The company is in a good position with regard to reserves and liquidity.

Meta materials stock